EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?

Kristel Lourdault, Arthur W Cowman, Douglas Hanes, Anthony J Scholer, Tyler Aguilar, Richard Essner

Journal of Surgical Oncology · 2025

DOI: 10.1002/jso.27976 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Kristel Lourdault und 5 weiteren Autor:innen. Beteiligte Einrichtung: Saint John's Cancer Institute at Providence St. John's Health Center, Santa Monica, California, USA. Hauptthemen laut MEDLINE: Nomograms, Melanoma, Sentinel Lymph Node, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was supported by the Borstein Family Melanoma Program, the Melamed Family Foundation, the John Wayne Cancer Foundation, and the Donald L Morton Mela….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Clinical nomograms have been developed to predict sentinel lymph node (SLN) status in early‐stage melanoma patients, but the clinical utility of these tools remains debatable. We created and validated a nomogram using data from a randomized clinical trial and assessed its accuracy against the well‐validated Melanoma Institute Australia (MIA) nomogram.

Methods

We developed our model to predict SLN status using logistic regression on clinicopathological patient data from the Multicenter Selective Lymphadenectomy Trial‐I. The model was externally validated using the National Cancer Database (NCDB) data set, and its performance was compared to that of the MIA nomogram.

Results

Our model had good discrimination between positive and negative SLNs, with a training set area under the curve (AUC) of 0.706 (0.661–0.751). Our model achieved an AUC of 0.715 (0.706–0.724) compared to 0.723 (0.715–0.731) with the MIA model, using the NCDB set.

Conclusion

Our model performed similarly to the MIA model, confirming that despite using different clinical features and data sets, no clinical nomogram is currently accurate enough for clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NomogramsMelanomaSentinel Lymph NodeSkin NeoplasmsSentinel Lymph Node BiopsyHumansFemaleMaleMiddle AgedLymph Node ExcisionAgedLymphatic MetastasisAdultPrognosis

Stichwörter der Autor:innen

MSLT‐INCDBmelanomanomogramrisk assessmentsentinel lymph node biopsysurgery

Autor:innen und Institutionen

  • Saint John's Cancer Institute at Providence St. John's Health Center, Santa Monica, California, USA.
  • Providence Research Network, Portland, Oregon, USA.

Förderung

  • This study was supported by the Borstein Family Melanoma Program, the Melamed Family Foundation, the John Wayne Cancer Foundation, and the Donald L Morton Mela…

Zitieren

APA

Lourdault, K., Cowman, A. W., Hanes, D., Scholer, A. J., Aguilar, T., & Essner, R. (2025). Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27976

Vancouver

Lourdault K, Cowman AW, Hanes D, Scholer AJ, Aguilar T, Essner R. Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?. Journal of Surgical Oncology. 2025. doi:10.1002/jso.27976

BibTeX
@article{Lourdault2025,
  author = {Lourdault, Kristel and Cowman, Arthur W and Hanes, Douglas and Scholer, Anthony J and Aguilar, Tyler and Essner, Richard},
  title = {Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?},
  journal = {Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1002/jso.27976}
}
Kostenlos starten →